Effects of combined metformin and semaglutide therapy on body weight, metabolic parameters, and reproductive outcomes in overweight/obese women with polycystic ovary syndrome: a prospective, randomized, controlled, open-label clinical trial

Abstract Objective This study aimed to assess the effects of metformin (MET) monotherapy versus a combination of semaglutide and MET on weight, metabolism, reproductive function, and inflammatory markers in women with polycystic ovary syndrome (PCOS). Methods A total of 100 overweight or obese women...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Haiyan Chen, Xiaohui Lei, Zhuoran Yang, Yuxin Xu, Dongfang Liu, Cong Wang, Hu Du
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2025-07-01
Serie:	Reproductive Biology and Endocrinology
Soggetti:	Semaglutide Polycystic ovary syndrome Metformin Pregnancy outcomes
Accesso online:	https://doi.org/10.1186/s12958-025-01447-3
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!